Avanos Medical, Inc. (AVNS)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$24.99+0.04%
Close 2026-07-24 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
Research Workspace
Put AVNS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Cash flow from operating activities: OCF -12.3M vs >0 target.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthManagement screens strong on earnings delivery, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 22% growth a year, above the roughly 2% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 0% a day.
View RiskAVNS's growth relies on maintaining strong revenue performance amid a supportive sector backdrop. Revenue grew 8.8% year over year, and the last quarter beat expectations. It trades at a premium compared to sector peers, which suggests that growth is already priced in. The primary risk is the cash flow from operating activities, which is currently negative at -12.3 million. Peer multiples imply a price about 12% above where it trades. This read is provisional; the thesis is on watch due to pressure on cash flow.
Trailing returns as of 2026-07-24. AVNS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 1 analyst currently covering AVNS (as of Aug 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare AVNS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AVNS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care Supplies — fair value, gap to price, and forward P/E.
Compare the value case
Put AVNS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-24. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.